Announce Date | 08/06/2025 |
EPS Normalized Actual | $2.6 (Beat by $0.11) |
EPS GAAP Actual | $2.6 (Beat by $0.11) |
Revenue Actual | $5.9766B |
Revenue Surprise | Beat by $5976.6M |
Announce Date | 07/01/2025 (Pre-Market) |
EPS Normalized Estimate | $2.81455 |
EPS GAAP Estimate | $2.81455 |
Revenue Estimate | $5.756070178B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2028 | 11.39731 | 14.89 | 11.16761 | 11.77609 | 1 |
Dec 2027 | 12.85679 | 13.2 | 12.44357 | 13.56302 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ2 2025 (Jun 2025) | 2.06 | -0.77352 | 5.9766B | 9.26% | 185.57M |
FQ1 2025 (Mar 2025) | 1.7 | 1.7 | 5.1991B | 6.28% | 5199.1M |
FQ4 2024 (Dec 2024) | 1.98 | 1.98 | 5.186B | 3.23% | 5186M |
FQ3 2024 (Sep 2024) | 6.4 | 6.4 | 5.5166B | -2.02% | 5516.6M |
FQ2 2024 (Jun 2024) | 2.1 | 2.1 | 5.4234B | -3.74% | 5423.4M |
FQ1 2024 (Mar 2024) | 1.61 | 1.61 | 4.8727B | -4.73% | 4872.7M |
FQ4 2023 (Dec 2023) | 2.21 | 2.21 | 5.0185B | 100% | 5018.5M |
FQ3 2023 (Sep 2023) | 2.35 | 2.35 | 5.6283B | 100% | 5628.3M |
FQ4 Announce Date
07/01/2025 (Pre-Market)
Consensus EPS Estimates
2.81455
Consensus Revenue Estimates
5.756070178B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 2.95291 | -- | 2.81734 | 3.06659 | 2 |
FQ3 2027 (Sep 2027) | 3.35977 | -- | 3.25806 | 3.42939 | 2 |
FQ2 2027 (Jun 2027) | 2.84224 | -- | 2.75619 | 2.90114 | 2 |
FQ1 2027 (Mar 2027) | 2.21592 | -- | 2.1498 | 2.26285 | 2 |
FQ4 2026 (Oct 2026) | 3.62901 | -- | 3.55116 | 3.74452 | 3 |
FQ3 2026 (Jul 2026) | 2.99455 | -- | 2.93031 | 3.08987 | 5 |
FQ2 2026 (Jun 2026) | 3.11765 | 33.92 | 2.94372 | 3.19663 | 5 |
FQ1 2026 (Mar 2026) | 2.60601 | 34.77 | 2.46062 | 2.67203 | 3 |
FQ4 2025 (Oct 2025) | 3.07537 | 35.62 | 3.0094 | 3.17326 | 4 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Dec 2027) | 5.83B | -- | 5.62B | 6B | 3 |
FQ3 2027 (Sep 2027) | 6.75B | -- | 6.59B | 6.85B | 3 |
FQ2 2027 (Jun 2027) | 5.98B | -- | 5.84B | 6.07B | 3 |
FQ1 2027 (Mar 2027) | 5.24B | -- | 5.12B | 5.33B | 3 |
FQ4 2026 (Oct 2026) | 6.81B | -- | 6.69B | 6.97B | 4 |
FQ3 2026 (Jul 2026) | 6.04B | -- | 5.95B | 6.19B | 5 |
FQ2 2026 (Jun 2026) | 6.48B | 7.75 | 6.2B | 6.61B | 5 |
FQ1 2026 (Mar 2026) | 5.78B | 10.1 | 5.53B | 5.9B | 6 |
FQ4 2025 (Oct 2025) | 6.2B | 16.3 | 6.09B | 6.35B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
1
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | 2.83352 | 2.06 | -0.77352 | -37.55% |
FQ1 2025 (Mar 2025) | 1.7 | 1.7 | 100% | |
FQ4 2024 (Dec 2024) | 1.98 | 1.98 | 100% | |
FQ3 2024 (Sep 2024) | 6.4 | 6.4 | 100% | |
FQ2 2024 (Jun 2024) | 2.1 | 2.1 | 100% | |
FQ1 2024 (Mar 2024) | 1.61 | 1.61 | 100% | |
FQ4 2023 (Dec 2023) | 2.21 | 2.21 | 100% | |
FQ3 2023 (Sep 2023) | 2.35 | 2.35 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ2 2025 (Jun 2025) | $5.79B | $5.98B | $185.57M | 3.1% |
FQ1 2025 (Mar 2025) | $0B | $5.2B | $5199.1M | 100% |
FQ4 2024 (Dec 2024) | $0B | $5.19B | $5186M | 100% |
FQ3 2024 (Sep 2024) | $0B | $5.52B | $5516.6M | 100% |
FQ2 2024 (Jun 2024) | $0B | $5.42B | $5423.4M | 100% |
FQ1 2024 (Mar 2024) | $0B | $4.87B | $4872.7M | 100% |
FQ4 2023 (Dec 2023) | $0B | $5.02B | $5018.5M | 100% |
FQ3 2023 (Sep 2023) | $0B | $5.63B | $5628.3M | 100% |